A nonpeptide αVβ3 and αVβ5 integrin antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

SB-273005

Item No. 34404

Product Insert (PDF)
Technical Information
Formal Name
2,3,4S,5-tetrahydro-8-[2-[6-(methylamino)-2-pyridinyl]ethoxy]-3-oxo-2-(2,2,2-trifluoroethyl)-1H-2-benzazepine-4-acetic acid
CAS Number
205678-31-5
Molecular Formula
C22H24F3N3O4
Formula Weight
Purity
≥98%
Formulation
A solid
Acetonitrile: Slightly soluble: 0.1-1 mg/ml
SMILES
OC(C[C@@H]1CC2=CC=C(OCCC3=CC=CC(NC)=N3)C=C2CN(C1=O)CC(F)(F)F)=O
InChi Code
InChI=1S/C22H24F3N3O4/c1-26-19-4-2-3-17(27-19)7-8-32-18-6-5-14-9-15(11-20(29)30)21(31)28(12-16(14)10-18)13-22(23,24)25/h2-6,10,15H,7-9,11-13H2,1H3,(H,26,27)(H,29,30)/t15-/m0/s1
InChi Key
KSSPHFGIOASRDE-HNNXBMFYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    SB-273005 is a nonpeptide antagonist of αVβ3 and αVβ5 integrins (Kis =1.2 and 0.3 nM, respectively).1 In vivo, SB-273005 (30 and 60 mg/kg) reduces paw edema and increases bone density in a rat model of adjuvant-induced arthritis. It also reduces the number of T helper 2 (Th2) cells and production of IL-10 in pregnant mice when administered at a dose of 3 mg/kg.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Badger, A.M., Blake, S., Kapadia, R., et alDisease-modifying activity of SB 273005, an orally active, nonpeptide αvβ3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis. Arthirits Rheum. 44(1), 128-137 (2001).

    2. Wang, S., Yang, J., Wang, C., et alSB-273005, an antagonist of αvβ3 integrin, reduces the production of Th2 cells and cytokine IL-10 in pregnant mice. Exp. Ther. Med. 7(6), 1677-1682 (2014).